GlassScriptPhysician profile
Kerwin Omarre Scott
NPI 1629661020
$2,876.54
in general payments reported to CMS, 2019-2025
12 companies · $403 in 2025
The $403 reported for 2025 was more than what 79% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $544 · 2022: $529 · 2023: $366 · 2024: $1,034 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161 · Travel and Lodging: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.68 |
| Travel and Lodging | $642.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $877.88 | 2022-2025 | |
| Midmark Corporation | $789.81 | 2024 | |
| Salvin Dental Specialties, INC. | $342.46 | 2021 | |
| Geistlich Pharma, North America, INC. | $222.82 | 2022-2023 | Bio-Materials, Bio-Gide |
| Sprintray INC | $153.69 | 2025 | |
| Straumann USA LLC | $146.87 | 2021-2024 | |
| Zimmer Biomet Holdings, INC. | $112.57 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $97.06 | 2025 | Reblozyl |
| Gc America INC. | $57.87 | 2025 | Cytrans Granules |
| Patterson Companies, INC. | $41.86 | 2024 | |
| Biohorizons Implant Systems INC. | $19.00 | 2021 | |
| Dentsply Sirona INC | $14.65 | 2024 | Astra Tech Implant System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerwin Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.